Eupraxia Pharmaceuticals (EPRX) Earnings Date & Reports

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

EPRX is expected to report earnings to rise 5.46% to -23 cents per share on November 11

Eupraxia Pharmaceuticals EPRX Stock Earnings Reports

Q3'26

Est.

$-0.23

Q2'26

Est.

$-0.22

Q1'26

Missed

by $0.05

Q4'25

Missed

by $0.17

Q3'25

Missed

by $0.01

The last earnings report on August 11 showed earnings per share of -22 cents, beating the estimate of -22 cents. With 128.42K shares outstanding, the current market capitalization sits at 451.31M.

View a ticker or compare two or three

EPRX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days